Pay in 4 interest-free payments of $5.81 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
In the Phase 2 Retatrutide trial, dose-dependent increases in heart rate were observed, which peaked at around 24 weeks and declined thereafter
It is not authorized under the Food and Drugs Act, does not carry a Drug Identification Number (DIN), Natural Product Number (NPN), or Homeopathic Drug Number (DIN-HM) issued by Health Canada, and is not intended to diagnose, treat, cure, or prevent any disease
If the goal is understanding how growth hormone works in biological systems
GHK-Cu downregulates acute-phase and pro-inflammatory cytokines (TNF-?, IL-6), upregulates anti-oxidant defenses (including superoxide dismutase, Nrf2 and HO-1 pathways), and suppresses fibrotic signaling by inhibiting TGF-?1/Smad2/3 activation
